logo
Moderna cancels Japan mRNA plant plans amid weak demand

Moderna cancels Japan mRNA plant plans amid weak demand

Nikkei Asia4 days ago
Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business environment.
YURIKA YONEDA
TOKYO -- U.S. drugmaker Moderna has scrapped plans to build a messenger RNA (mRNA) vaccine plant in Japan, citing sluggish vaccine demand and poor business performance.
"After careful consideration in light of the current business environment, we have decided not to proceed with this plan at this time," Moderna's Japanese subsidiary stated in a news release on Friday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nissan fans stay loyal but worry about turmoil: Nikkei poll
Nissan fans stay loyal but worry about turmoil: Nikkei poll

Nikkei Asia

time23 minutes ago

  • Nikkei Asia

Nissan fans stay loyal but worry about turmoil: Nikkei poll

Nissan has made no full redesigns of flagship models since 2022, leaving it struggling to draw customers to dealerships. © Reuters TAKAKO FUJIU and RISAKO KOJIMA TOKYO -- As Nissan Motor grapples with sluggish sales, exacerbated by a lack of fresh offerings, Nikkei asked current drivers of Nissan cars whether they will stick with the Japanese automaker despite its tribulations. When asked what car they want to drive next, 58% of the 104 respondents said they plan to go with Nissan again. Of the rest, 12% look to switch to a model from Toyota Motor and 8% to Honda Motor, with some others naming imported brands such as BMW and Mercedes-Benz.

Foreign buyers' growing sway in ultralong JGBs raises stability risks
Foreign buyers' growing sway in ultralong JGBs raises stability risks

Nikkei Asia

timean hour ago

  • Nikkei Asia

Foreign buyers' growing sway in ultralong JGBs raises stability risks

TOKYO -- The market for ultralong-term Japanese government bonds (JGBs) is becoming increasingly reliant on international investors drawn to relatively low prices and a steep yield curve, raising concerns about potential risks posed to supply and demand stability. Foreign investors bought 1.5 trillion yen ($10.2 billion) in ultralong JGBs on a net basis in June, according to data released Tuesday by the Japan Securities Dealers Association. This is the third-highest monthly tally in QUICK data going back to 2004, behind only April and March of this year. For the January-June half, foreign investors bought 8.8 trillion yen more in bonds than they sold.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store